C-JNNGIsomorphic Labs
AI drug discovery, machine learning, digital biology
discoverydiscoveringsmall molecule
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-JNNG
C-JNNGC-JNNGAI drug discovery, machine learning, digital biology
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Isomorphic Labs AI drug discovery, machine learning, digital biology
Isomorphic Labs is advancing human health by building on and beyond the AlphaFold system. Its interdisciplinary team of drug discovery experts and machine learning specialists has built predictive and generative AI models to accelerate scientific discovery. The company aims to model complex biological phenomena, design novel molecules, anticipate drug performance, and develop medicines for devastating diseases.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Isomorphic Labs — Early mechanism · Lower middle. Derived deterministically from 11 extracted project(s). Most-advanced status: preclinical. Band: early_mechanism. Modifiers: +5 depth (3 programs at preclinical).…
Source: Deterministic